James Bramble

James Bramble has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Usana Health Sciences Inc and AGNT, Inc. Between 8 August 2008 and 13 November 2024, the trades on record add up to 53 filings.

On the open market, the record shows 1 purchase worth €16k and 27 sales worth €8.8M. The net balance comes to €8.8M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 25 option exercises. Since January 2024: no purchases and 1 sale on the market.

The latest filing, published on 13 November 2024, reports an open-market sale of €331k in AGNT, Inc. The last insider purchase was made public on 3 December 2012, 5,073 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.